VanHelene A, Hadfield M, Trapani D, Warner J, Lythgoe M
BMJ Oncol. 2025; 3(1):e000410.
PMID: 39886121
PMC: 11347684.
DOI: 10.1136/bmjonc-2024-000410.
Lamont E, Stein E, Tarantino P, Tolaney S, Ahlberg C, Chinnathambu K
Breast Cancer Res Treat. 2024; 210(1):11-14.
PMID: 39707103
DOI: 10.1007/s10549-024-07581-7.
von der Grun J, Ahmadsei M, Breyer I, Britschgi C, Eberli D, Hermanns T
Neoplasia. 2024; 46:100946.
PMID: 39491410
PMC: 10630114.
DOI: 10.1016/j.neo.2023.100946.
Schpero W, Takvorian S, Blickstein D, Shafquat A, Liu J, Chatterjee A
J Clin Oncol. 2024; 42(27):3238-3246.
PMID: 39052944
PMC: 11408099.
DOI: 10.1200/JCO.23.01149.
Smith K, Mead-Harvey C, Mazza G, Shinn E, Frank E, Melisko M
Cancer Med. 2024; 13(5):e7090.
PMID: 38466037
PMC: 10926883.
DOI: 10.1002/cam4.7090.
Head and Neck Cancer Patient Population, Management, and Oncologic Outcomes from the COVID-19 Pandemic.
Bloom J, Rodriguez-Russo C, Hsieh K, Dickstein D, Sheu R, Jain M
Curr Oncol. 2024; 31(1):436-446.
PMID: 38248114
PMC: 10814981.
DOI: 10.3390/curroncol31010029.
Impact of Coronavirus Disease 2019 on Gastric Cancer Diagnosis and Stage: A Single-Institute Study in South Korea.
Hong M, Choi M, Lee J, Kim K, Kim H, Lee C
J Gastric Cancer. 2023; 23(4):574-583.
PMID: 37932224
PMC: 10630563.
DOI: 10.5230/jgc.2023.23.e36.
Enrollment Success, Factors, and Prediction Models in Cancer Trials (2008-2019).
Zhang S, Zhang J, Liu S, Pang H, Stinchcombe T, Wang X
JCO Oncol Pract. 2023; 19(11):1058-1068.
PMID: 37793091
PMC: 10667018.
DOI: 10.1200/OP.23.00147.
The changing landscape of clinical trials in Australia.
Seidler A, Willson M, Aberoumand M, Williams J, Hunter K, Barba A
Med J Aust. 2023; 219(5):192-196.
PMID: 37573518
PMC: 10952960.
DOI: 10.5694/mja2.52059.
Non-COVID-19 UK clinical trials and the COVID-19 pandemic: impact, challenges and possible solutions.
Lorenc A, Rooshenas L, Conefrey C, Wade J, Farrar N, Mills N
Trials. 2023; 24(1):424.
PMID: 37349850
PMC: 10286467.
DOI: 10.1186/s13063-023-07414-w.
Quantifying the impact of the COVID-19 pandemic on clinical trial screening rates over time in 37 countries.
McDonald K, Seltzer E, Lu M, Gaisenband S, Fletcher C, McLeroth P
Trials. 2023; 24(1):254.
PMID: 37013558
PMC: 10071259.
DOI: 10.1186/s13063-023-07277-1.
Revitalising cancer trials post-pandemic: time for reform.
Morton C, Sullivan R, Sarker D, Posner J, Spicer J
Br J Cancer. 2023; 128(8):1409-1414.
PMID: 36959378
PMC: 10035974.
DOI: 10.1038/s41416-023-02224-y.
Addressing multilevel barriers to clinical trial participation among Black and White men with prostate cancer through the PACCT study.
Eggly S, Senft N, Kim S, Heath E, Jang H, Moore T
Cancer Med. 2022; 12(7):8604-8613.
PMID: 36540051
PMC: 10134336.
DOI: 10.1002/cam4.5552.
Impact of the COVID-19 pandemic on the diagnosis and treatment of onco-hematologic patients: a discussion paper.
Bouza E, Martin M, Ales J, Aragones N, Barragan B, de la Camara R
Rev Esp Quimioter. 2022; 36(1):1-25.
PMID: 36322133
PMC: 9910677.
DOI: 10.37201/req/087.2022.
Defining Radiation Treatment Interruption Rates During the COVID-19 Pandemic: Findings From an Academic Center in an Underserved Urban Setting.
Gaudio E, Ammar N, Gunturkun F, Akkus C, Brakefield W, Wakefield D
Int J Radiat Oncol Biol Phys. 2022; 116(2):379-393.
PMID: 36183931
PMC: 9584778.
DOI: 10.1016/j.ijrobp.2022.09.073.
Position paper of the Italian Association of Medical Oncology on the impact of COVID-19 on Italian oncology and the path forward: the 2021 Matera statement.
Beretta G, Casolino R, Corsi D, Perrone F, Di Maio M, Cinieri S
ESMO Open. 2022; 7(4):100538.
PMID: 35921761
PMC: 9222406.
DOI: 10.1016/j.esmoop.2022.100538.
Oncology During the COVID-19 Pandemic: a Lockdown Perspective.
Boniface D, Tapia-Rico G
Curr Oncol Rep. 2022; 24(10):1219-1235.
PMID: 35622263
PMC: 9136209.
DOI: 10.1007/s11912-022-01301-4.
Impact of COVID-19 Pandemic Declaration on New Oncology Trial Commencements: An Interrupted Time Series with Segmented Regression Analysis.
Bin H, Jeong S, Lee H
Healthcare (Basel). 2022; 10(3).
PMID: 35326967
PMC: 8953517.
DOI: 10.3390/healthcare10030489.
The Impact of COVID-19 on the Initiation of Clinical Trials in Europe and the United States.
Lasch F, Psarelli E, Herold R, Mattsson A, Guizzaro L, Petavy F
Clin Pharmacol Ther. 2022; 111(5):1093-1102.
PMID: 35090044
PMC: 9015398.
DOI: 10.1002/cpt.2534.
Cancer Research in the Time of COVID-19: A Colombian Narrative.
Murillo R, Fernandez-Deaza G, Zuluaga M, Lewison G, Usgame-Zubieta D, Usgame-Zubieta I
Front Public Health. 2022; 9:750755.
PMID: 35059373
PMC: 8764311.
DOI: 10.3389/fpubh.2021.750755.
